Dimeric IAP inhibitors

Details for Australian Patent Application No. 2011219862 (hide)

Owner Novartis AG

Inventors Straub, Christopher Sean; Chen, Zhuoliang; Palermo, Mark G.

Agent Davies Collison Cave

Pub. Number AU-A-2011219862

PCT Pub. Number WO2011/104266

Priority 61/308,114 25.02.10 US; 61/333,927 12.05.10 US; 61/388,410 30.09.10 US

Filing date 23 February 2011

Wipo publication date 1 September 2011

International Classifications

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

A61K 31/4439

A61P 35/00 Antineoplastic agents

C07K 5/06 Peptides having up to four amino acids in a fully defined sequence

Event Publications

6 September 2012 PCT application entered the National Phase

  PCT publication WO2011/104266 Priority application(s): WO2011/104266

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011219865-Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient

2011219842-Watermark decoder and method for providing binary message data